Using Net Benefits to Report Cost-Effectiveness Results, PPT by K. O

Presentation at ISPOR Europe, Nov. 2011, by Ken O’Day, PhD, Director, Xcenda, LLC, Palm Harbor, FL, USA; Denise Globe, PhD, Senior Director, Global Health Outcomes Strategy and Research, Allergan, LLC, Irvine, CA, USA

You might also be interested in:

ISPOR Releases Final Program, Speakers for ISPOR Europe 2018 October 31, 2018
ISPOR Outlines Milestones in 2018 Annual Report May 7, 2019
Study: Payer Experts Say PIE Needs Legislative Safe Harbor February 2, 2019
HTA in Europe: Key Success Factors for Positive HTA Recommendations June 21, 2018
Value in Health Announces Study on Cost-Effectiveness Analyses, Cost June 24, 2018
ISPOR 2019 Issues Call for Abstracts October 3, 2018
ISPOR Accepting Nominations for Upcoming Scientific Awards January 4, 2019